CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net loss	$ (2,433,970)	$ (8,163,662)
Adjustments to reconcile net loss to cash used in operating activities
Depreciation and amortization	11,356	12,662
Bad debt	35,843	(24,868)
Gain on disposition	0	(50,695)
Amortization of debt discount	174,898	159,335
Loss on settlement of non-redeemable convertible notes	1,093,735	6,775,835
Change in operating assets and liabilities
Accounts and taxes receivable	(31,297)	(29,575)
Prepaid expense	10,000	(10,000)
Inventory	38,227	21,648
Deferred revenue	0	(22,221)
Accounts payable and accrued liabilities	859,184	887,881
Operating lease right-of-use liability	(8,479)	(8,272)
Net cash used in operating activities	(250,503)	(451,932)
Cash flows from investing activities
Net cash used in investing activities	0	0
Cash flow from financing activities
Expenses paid for by related party	62,928	108,383
Repayment of advances to related party	(45,278)	(34,246)
Proceeds from notes payable	0	105,001
Repayment of notes payable	0	(7,037)
Proceeds from line of credit	211,100	286,529
Net cash provided by financing activities	228,750	458,630
Change in foreign exchange	(865)	516
Net change in cash	(22,618)	7,214
Cash, beginning of the period	24,351	17,137
Cash, end of the period	1,733	24,351
Cash paid during the period
Interest paid	0	0
Income taxes paid	0	0
Supplemental disclosure of non-cash investing and financing activities
Stock issued for settlement of debt - related party	296,000	188,871
Stock issued for settlement of promissory notes	133,200	0
Stock issued for settlement of promissory notes - related party	0	85,922
Stock issued to settle non-redeemable convertible notes	1,047,057	6,894,482
Issue of new promissory notes to settle promissory notes, accrued expenses and other liabilities	2,081,016	0
Deemed contribution - Series A Stock Modification	0	190,040
Deemed contribution - Series C Stock Modification	$ 0	$ 2,211,884